Which factors predict biopsy reclassification in men on surveillance for prostate cancer?
High genomic score, prostate-specific antigen (PSA) kinetics, and PSA density ≥0.15 are predictive of biopsy reclassification within 3 years of commencing active surveillance, according to a study. Moreover, the association of PSA kinetics and PSA density ≥0.15 with reclassification persists at 5 years following diagnosis.